Abstract:Abstract Background: Immune-checkpoint inhibitors (ICI) such as anti-PD-L1 have shown promise in solid tumors with high mutational burden and immune infiltration such as melanoma. However, ICI have shown have only shown mild success in prostate cancer. One likely explanation is that majority of prostate cancer have low mutational burden leading to poor immune infiltration. However, exceptions to the immune infiltration have been observed in a subset of locally advanced prostate cancer specimens. We hypothesized that specific immune subsets, particular myeloid progenitor cells, drive microenvironmental differences between hot and cold tumors. Methods: A total of four formalin-fixed paraffin-embedded tissue punch samples were obtained from biobank at UCLA and were sectioned at 5μm thickness. The sections were deparaffinized and de-crosslinked per manufacture’s instructions, followed by spatial transcriptome profiling using the Visium (10x Genomics) platform. Libraries were constructed from RNA and sequenced on Illumina platform. The reads were processed using Spaceranger. Spot level read counts were first filtered by gene detection rate, total gene count and mitochondrial content. Spots passing QC were normalized and clustered based on the top 2000 most highly variable genes. Cell-cell communication was assessed using the LIANA ligand-receptor analysis framework. To identify regions of inflammation, cell type deconvolution was performed using SpatialDWLS (dampened weighted least squares) and gene-set enrichment was performed using ssgsea from GSVA package. All analysis and statistics were perform using R version 4.1. Results: The number of spots passed QC ranged from approximately 3400 – 4000. Clustering by gene expression resulted in 14 – 23 clusters that showed high concordance with expert pathologist annotation of tumor and tumor subtype mapping to intraductal carcinoma and invasive carcinoma. Cell-type deconvolution by SpatialDWLS found that different tissue regions harbored approximately 1.5-4.5% of immune cells. The myeloid fraction was 0.8%- 3% and T-cells of total immune cells, representing 0.4% - 0.9% of the total cell population. These regions with myeloid cell enrichment were associated with elevated interferon alpha and gamma response, as well as IL2-STAT5 signaling in geographically proximal regions. Conclusion: The presence of myeloid cells in the microenvironments of immunologically “hot” tumors may represent a major factor contributing to immunosuppression in tumors predicted to respond to ICI. Ongoing efforts profiling “hot” tumors will assess the feasibility of modulating myeloid cells in order to recruit cytotoxic T cells. Citation Format: Anson Ku, Rong Rong Huang, Huihui Ye, Adam Sowalsky. Spatially-resolved cell-cell interactions between tumor microenvironment and immunologically “hot” and “cold” locally advanced prostate tumors [abstract]. In: Proceedings of the AACR Special Conference: Advances in Prostate Cancer Research; 2023 Mar 15-18; Denver, Colorado. Philadelphia (PA): AACR; Cancer Res 2023;83(11 Suppl):Abstract nr B030.

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment

Immune Response Drives Outcomes in Prostate Cancer: Implications for Immunotherapy

Comprehensive Analysis to Identify IL7R As a Immunotherapy Biomarker from Pan-Cancer Analysis to in Vitro Validation.

IL-7R Expression Correlates with Prognosis in Breast Cancer

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression

IL-38 promotes the development of prostate cancer

Abstract B030: Spatially-resolved cell-cell interactions between tumor microenvironment and immunologically “hot” and “cold” locally advanced prostate tumors

Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile

Upregulation of TIM3 and reduced expression of PD-1 on immune cell subsets in advanced prostate cancers

Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy

Abstract 304: Reactive Oxygen Species Induce Prostate Cancer Cells Via Activation of the IL6/STAT3 Pathway.

Loss of Monocyte in Tumor Microenvironment Promotes Metastasis Based on Large-Scale Prostate Cancer Cohorts

Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization study

Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer

Abstract 7351: Delineating the prostate cancer tumor microenvironment through scRNA-seq profiling at different timepoints

Causal relationship between immune cells and prostate cancer: a Mendelian randomization study

Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer

Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression

IL-8 Produced Via Bidirectional Communication Between Prostate Cancer and M2 Macrophages as a Potential Diagnostic and Prognostic Biomarker